Sociedad Química y Minera de Chile S.A. (SQM) Earnings Call Transcript
March 2, 2026
Earnings Call Speaker Segments
Good day, everyone, and thanks for joining SQM's call about our results for Q4 and fiscal 2025 in full. This session is being recorded and is also available as a live web stream. Our earnings press release, along with the accompanying presentation, can be accessed on our website, where you'll also find the link for the webcast. On the line with us today: Mr. Ricardo Ramos, who serves as our Chief Executive Officer; Mr. Gerardo Illanes, our Chief Financial Officer; Mr. Carlos Diaz, CEO of Nova Andino Litio; Mr. Pablo Altimiras, who heads the Iodine and Plant Nutrition division as CEO; and Mr. Mark Fones, CEO of the International Lithium Division. Joining us as well are teammates from Commercial and Business intelligence: Felipe Smith, who serves as Commercial Vice President of Nova Andino Litio; Pablo Hernandez, Vice President of Strategy and Development at Nova Andino Litio; Juan Pablo Bellolio, Commercial Vice President of Plant Nutrition and Specialty Products; Alvaro Araya, CFO of the International Lithium Division; Andres Fontannaz, Commercial Vice President of the International Lithium Division; and Max Fial, Head of Studies of the International Lithium Division. Prior to starting, kindly be aware that anything said on this call concerning our business outlook, future economic performance, anticipated profitability, revenues, expenses and other financial items, together with expected cost synergies and growth in product or service lines, falls under forward-looking statements as defined by U.S. federal securities laws. Such statements do not reflect historical facts and carry risks and uncertainties that might lead actual results to differ materially. We undertake no duty to revise these statements, except where the law demands it. For a complete discussion of forward-looking statements, kindly consult our earnings press release and presentation; with that, I'll hand the call over to Chief Executive Officer, Mr. Ricardo Ramos.
Hello, everyone, and thanks for being with us today. For SQM, 2025 mattered a great deal; we closed out the year by entering into our association agreement with Codelco, forming Nova Andino Litio, which allows for lithium production over the long term out of the Salar de Aacama. Alongside that, we posted robust financial results, made our operational performance better throughout our main businesses and keep moving our long-term growth strategy forward. Across the whole of 2025, revenues came in at $44.6 billion, a bit above the prior year, alongside net income of $588 million. Those outcomes speak to better market conditions, solid execution on operations and the resilience of our diversified portfolio. In the fourth quarter, performance was especially strong in lithium and iodine, 2 of our most strategic businesses. Within Lithium, we hit record quarterly sales volumes in both our Chilean and international operations. At Nova Andino Litio, fourth-quarter sales volumes surpassed 66,000 metric tons, up more than 50% year-over-year, which shows the expansion efforts put in place over the past several years. On the market side, we started to notice a significant shift as the year drew to a close. As we said on our previous conference call in November, an inflection point in lithium prices appeared, fueled by demand from energy storage system that beat expectations, along with some supply disruptions. That helped create a tighter market environment and better pricing trends. Consequently, our average realized lithium price rose almost 14% quarter-over-quarter, getting close to $10 per kilogram in the fourth quarter. With the demand momentum observed in recent months and only limited new supply coming into the market, we anticipate the pricing environment to be significantly stronger in the first quarter. Going forward, we still see strong long-term fundamentals for lithium, primarily driven by electric vehicles and energy storage systems. On the operational front, Nova Andino Litio is presently running at full capacity while we keep advancing expansion plans in the Salar de Atacama. In our International Lithium division, the Mount Holland mine and concentrator did well and the Kwinana refinery keeps moving through the ramp-up phase. Early this year, we also marked the first shipment of lithium hydroxide from the Kwinana refinery in Australia, a milestone underscoring the progress of our international lithium strategy. Turning to iodine. This business contributed strongly, accounting for roughly 42% of SQM's total gross margin during the year. By the close of 2025, we saw record iodine prices, backed by tight supply conditions and strong demand, especially in the x-ray contrast media market. Looking forward, we estimate the iodine market could grow by around 3% in 2026, and our sales volumes should stay stable or rise slightly depending on market conditions. We anticipate being able to complete the seawater pipeline initiative in Tarapaca, which is going to deliver extra operational flexibility and ought to let us unlock additional production capacity; within Specialty Plant Nutrition, we recorded 3% volume growth across the year, fueled by specialty blends and value-added products. Looking at 2026, we're expecting moderate volume growth somewhere between 2% and 4%, set against a stable pricing backdrop. Before wrapping up, I'd also like to call attention to the progress we keep making on sustainability. Across 2025, SQM improved its ESG performance and earned notable international recognition, among it inclusion in the SP Global Sustainability Yearbook 2026 along with strong ratings from Dow Jones Sustainability Index, MSCI and EcoVadis. In closing, we're heading into 2026 carrying strong operational momentum, better lithium market conditions and ongoing strength in Iodine and Specialty Plant Nutrition. Our teams stay focused on providing dependable supply to our customers, carrying out our growth projects and generating long-term value for our shareholders. Thanks for being with us today. I'll now hand the call to the operator for the Q&A session.
Two things I want to ask about lithium. First, you're expecting a 10% sales increase in 2026 from the Chile operations. Could you take a moment to walk through the product mix on the production side — would the company be open to leaning a bit more toward sulfate in 2026, perhaps as a route to ramping output quickly? Are you running your China plant at full utilization, and have you managed to toll additional capacity there? Basically, what does the production mix outlook look like. Also, could you share some production figures for the JV? Second, on production costs in the fourth quarter, they climbed a lot versus the prior quarter. My guess is that's tied to lease payments because average prices were higher. Just want to check whether anything else is driving production costs — perhaps sulfate operations are somewhat more costly. In any case, any detail on the production cost side would be welcome.
Lucas, Felipe Smith here. On your first point, 2026 sales volume. We're aiming for robust sales volume in Q1. Our hope is to beat Q1 '25 sales volume by over 15%, which would set a record for the first calendar quarter as well. Just as we've done consistently through the years, our strategy hasn't changed: run at full capacity and expand in step with expected market growth, making sure we're always ready to serve our customers' needs. In line with that approach, we're confident we'll place successfully in the market the extra production we anticipate delivering this year, roughly 260,000 tons. There's demand for lithium units in the market, particularly across Asia Pacific. I'll let — Carlos will speak to the product mix.
Lucas, Carlos Diaz here, CEO of Nova Andino. Regarding production, to start with, throughout 2025 our output followed the plan, hitting 234,000 LCE. Of that total, 50 came from China, generated from our lithium sulfate operations at the Salar de Atacama. Looking at this year, we've raised our production outlook, and we're aiming to reach roughly 260,000 on a lithium carbonate equivalent basis, with growth coming from both our Chilean and Chinese operations. That was also the pattern over the past year, in '25, and we anticipate continuing to lift our productivity, powered by efficiency gains and the adoption of new technology, while at the same time cutting the traction in line with our sustainability strategy. And this year, we'll keep full flexibility when it comes to lithium carbonate and lithium hydroxide, in Chile as well as China. I realize you're asking about machine; we're currently running at full capacity too.
Lucas, Mark Fones here, calling from SQM International Lithium division. On our side, we're likewise anticipating that sales will climb by roughly 10% measured on an LCE basis. Since we've finished ramping up the concentrator, we'll keep going and anticipate operating at full capacity at the Mount Holland concentrator; as a result, our sales will be largely steered by what we produce. Regarding how things split between spodumene concentrate and lithium hydroxide, the balance will lean and skew strongly toward spodumene concentrate while we carry on ramping up the lithium hydroxide plant in Kwinana.
Lucas, on your cost question — I believe those figures contain an error. When you compare the total cost per ton for the Lithium and Derivatives division between the third quarter and the fourth quarter, the two are pretty close. Yet the average lithium price came in higher during the fourth quarter. So as a result, a larger share of the cost line consists of lease payments to CORFO. Keep in mind that the cost of goods sold includes costs from our Nova Andino Litio division as well as the International Lithium division, which is gaining importance when it comes to total volumes in that business line.
That was precisely what I was asking, Gerardo — whether anything besides the lease payments affected the quarter. It came through very clearly.
Nice work on these solid results. Your EPS reflects a hit from greater minority interest, yet no dividend to Codelco appears so far in the cash flow statement; therefore, 2 questions on that. To begin, could you give us some guidance for figuring out minority interest moving forward? Also, could you offer guidance on the timing of when dividend payments to Codelco will begin showing up, and in what way those dividends tie into the minority interest?
Andres, this is Ricardo Ramos. The specifics of the arrangement with Codelco are publicly available, and it is a shareholders' agreement covering how the dividend owed to Codelco gets calculated annually. Put quite simply, though, you take Nova Andino's net income, and out of that share, the bulk of Nova Andino's net income ties to the lithium business. As of now, 33,500 metric tons of lithium go to Codelco, with the remainder going to SQM. Applying that ratio, we split the net income between the two companies. That's the straightforward approach. It's actually somewhat more involved than that, but it's public, and you're able to look it over in the shareholders' agreement between both parties. Our expectation is to make those dividend payments in April — I believe in April, May, though my sense is April will be the month. Each quarter, we'll put out our best estimates and assumptions regarding the share of the dividend for Codelco that will be paid once the year ends.
So, one more question, if that's alright. Regarding the profit we're observing, does the minority interest represent a share tied to the 33.5 kilotons, or does it represent a share of the 50% that Codelco holds?
Concerning the minority interest, what we do is distribute the dividend to Codelco, and that dividend corresponds to the 33,500 metric tons of lithium along with the net income attributed to those 33,500 metric tons.
Ben Isaacson here with three things to go over, and I want to take them individually. Starting with iodine: during Q4 you moved a lot more product than I believe the Street had modeled, yet at the same time you're guiding toward steady volumes in '26, particularly since the seawater pipeline is due to start up. What I'm wondering is why Q4 came in above expectations on sales, while '26 volumes stay level, despite that pipeline entering the picture?
Pablo Altimiras here, Ben. What I'd point to is that certain third-party capacity we had counted on didn't materialize — that explains why Q4 ultimately came in higher for us. On top of that, the demand side is showing encouraging signs. In fact, iodine demand growth last year came in above what had been anticipated. Based on our figures, demand ultimately expanded 0.6%, versus an outlook of roughly no growth at all. That was an encouraging signal, and it means we have product available to supply. As for this year, we do anticipate some capacity. Specifically, we expect new projects in Chile to come through. Our initial view was the first semester. As things stand now, it may land in the second semester instead. So — that's why we ultimately expect to move roughly the same quantity. That said, as you're aware, SQM's approach is to keep adding capacity, and with this new project our aim is to have the capacity needed to meet what the market requires.
My next question concerns Tianqi. They've submitted a filing indicating they're now selling actively, I believe possibly around 3 million shares, and that figure might increase. Since you're seeing much stronger lithium pricing, iodine performing nicely, and potash plus the SPN business looking healthy, have you held any talks about possibly repurchasing a portion of those shares to keep them off the market? If not, would you be open to exploring that?
First, no discussions of that nature are taking place on our side. Second, legally speaking, repurchasing shares isn't permitted in Chile.
All right, that one's simple. Now for my third question. This year we're beginning to witness sodium-ion batteries truly take off and get better on important measures such as cost, energy density, and so on. Could you discuss the dangers that sodium ion poses to the expansion of lithium demand, both for EVs and for energy storage? And what steps are you taking to handle those dangers?
Ben, this is Pablo Hernandez. As you said, we have in fact been hearing quite a bit about sodium-ion batteries in the marketplace. Even so, when we talk with the market and read the market, our conviction remains strong that the item best positioned for use in these batteries is lithium. A modest possible market niche does exist, in our view, for sodium-ion batteries, yet our belief is very firm that for the future, the dominant technology will be lithium.
I'd like to revisit the lithium forecast for this year. You referenced a fairly robust 1Q, up 15% versus a year ago. Could you discuss how you expect things to trend from 2Q through 4Q? And perhaps you could also tell us what you're picking up from your Chinese customer — just to gauge the sentiment around what they're observing in the market.
Yes, Corinne, this is Felipe. Right. Well, as I mentioned earlier, 15% in the first quarter versus Q1 '25. And quarter over quarter, we anticipate volumes rising, culminating in — we hope — the biggest volume during Q4, all right? Like I noted in response to the earlier question too, our plan is to sell roughly in step with the growth in output. That said, should chances arise to move a little extra, naturally we'll pursue them. For your awareness, at present over 80% of what we move is already under contract. That leaves us some room for spot sales as we work to get the most out of our opportunities and margins; and regarding your question on Chinese customers. Well, like I also mentioned, appetite for lithium units is strong, particularly across Asia Pacific, and China is no different; quite the opposite — we've received many inquiries aiming to boost our volumes, though we prefer a highly diversified customer portfolio. So we handle that with care.
Perhaps one more thing. Could you discuss what you're expecting on pricing? You said roughly 80% is locked in under contract. My assumption is that reflects today's pricing, or what we've observed over the past 3 months. Could you remind us how you think about it where the contract is concerned? And then, more broadly, what's your outlook on pricing for the market this year?
Yes; naturally this is the finest question, and nobody has the answer, but I'll give it a shot. Having hit the bottom point in 4 years during the second quarter of 2025, our average sales price got to approximately $10 in Q4 '25, in line with market indices, which is welcome news. As ever, our realized prices stay mostly tied to those price indices. So our sales price in Q1, I can tell you right now, will be considerably above Q4 2025. That's one piece of very good news. Yet if you want me to look farther out than that, it gets harder. All I can say is that pricing will stay volatile during this year. Predicting what happens across the remaining quarters is extremely hard. What I can state, though, without my boss getting angry at me, is that prices ought to sit nearer to present price levels than to the levels from last year. I hope that works for you, Corinne.
Let me ask a follow-up. In your presentation, Chile's capacity is going up to 240,000 tons by 2028, while the earlier deck indicated 2026. So I'm just trying to figure out what caused that shift? And it looks like you're giving priority to China over Chile when it comes to capacity. Maybe that's because CapEx per ton is more efficient, I'm not certain. And I'd love to understand how we should frame production growth and the Chile versus China mix over the next couple of years. Second, on iodine, you just said you expect 3% demand growth, lot pricing. Clearly, profitability has been very strong these last few years. And it's always striking that the supply response has been fairly slow. You also suggested that growth anticipated in the later part of last year hasn't materialized either; so I'm just trying to gauge your conviction on the iodine market — can we keep seeing this level of profitability, and is there any risk of a supply response to these elevated prices?
Marcio, this is Carlos Diaz. On your lithium expansion question, the 240,000 expansion at our chemical plant Antofagasta has been pushed to 2028 because of an optimization and efficiency project we've been working on at Salar de Atacama, which lets us raise lithium sulfate production; but I should note that the total production we've forecast hasn't been impacted. In fact, our total production expected for this year is higher than what we announced previously. So in the end, it's a CapEx optimization, and we'll produce more each year.
Pablo Atimiras here. When it comes to your question on iodine, our outlook for this market is really quite favorable. As we've mentioned before, we expect demand to expand by 3% during this year, and that represents a significant increase relative to the growth recorded in the prior year; beyond that, over the long run, our demand view remains favorable as well. That's why we've been putting material resources into expansion. You'll recall that a few years back, we brought Pampa Blanca online. At present, we're bringing Maria Elena online. On top of that, we're nearly done with our seawater pipeline project, which will let us keep growing while gaining additional capacity and flexibility. Our approach is to be positioned to supply whatever iodine the market requires. In fact, through this new investment, we aim to produce over 15,000 metric tons in this year; and once the water — seawater pipeline project is complete, we expect to achieve a capacity exceeding 17,000 metric tons annually.
For the first item, would you mind giving us an update on how the Kwinana refinery ramp-up is progressing? Also, could you share a volume forecast for Mt Holland across 2026? Beyond that, please lay out where things stand right now with the engineering studies and the regulatory permits tied to the proposed expansion of the mine and concentrator. Should that expansion be able to move forward, what range of capital expenditure would be involved? My second question concerns your exploration work in Australia and in other international jurisdictions. An update there would be very useful as well.
Cesar, thank you for those questions. I will attempt to address each of them in turn. This is Mark Fones speaking. On your question about expanding the mine and concentrator, keep in mind that the final investment decision we are meant to make in the current year covers the mine and concentrator only. We anticipate bringing it before the respective Boards — that means both Wesfarmers and SQM — by the middle of this year. Its output remains subject, as you correctly noted, to the environmental approvals together with the engineering studies. Progress on both has been good. So before the decision, we expect to reach a relevant milestone on the approvals, which is advancing nicely. The engineering studies likewise continue to advance nicely. As all of you are aware, and as was typical for our earlier investment decision, we make our capital investment decisions once engineering has advanced beyond 30%; we expect to reach that point by the middle of this year. Notably, at the concentrator, we expect engineering progress of roughly 50%, so things there have been moving along well. As for your question on CapEx for the expansion, we have not yet settled on an investment CapEx figure, though I can say that within our 2025 and 2027 CapEx projection, we have set aside approximately $200 million for the concentrator expansion at Mt. Holland in 2027. Your following question concerned the Kwinana refinery along with production outputs and projections. Let me say first that at the mine and concentrator, as I briefly explained earlier, we are already producing at capacity. We expect to hold that capacity production during 2026; for SQM's 50% share, that ought to fall in a range of between 170,000 and 180,000 tonnes of 6% sodium concentrate. That represents our portion over the course of this year. The harder, more difficult question involves projection and guidance for production at Kwinana. As you are well aware, we have lately been in ramp-up. Producing precise figures under such circumstances is difficult. Even so, I can report that the ramp-up has been impacted by intermittent other issues, as our partners at Wesfarmers have briefed previously. It has already been addressed through the studies and engineering development. So we're looking at having that completed solution ready by the middle of this year; worth pointing out that our emissions have stayed inside approved limits regardless. Given that, our expectation now is that ramp-up shifts into 2027. As a result, like I said earlier, sales volumes will lean heavily toward spodumene concentrate again in 2026, which gives us the flexibility to sell profitable spodumene concentrate in the interim. On your exploration question, three main regions are where we're focused at present. Those being Australia, Namibia and Canada. Let me go over each of them briefly, probably; in Australia, we hold 4 earning agreements, or partners, if you will. Spread across Western Australia and the Northern Territories are those 4 early exploration agreements. Each sits at a different early stage, if you will. A couple are doing surface exploration and a couple already have drilling programs underway; progress and developments are what we expect during this year, 2026. The 2 drilling programs, should you be interested, are scheduled at Mount Roberts and in the Northern Territories areas where pegmatites have already been identified. Turning to our exploration activities outside Australia, still early days in Namibia. Our Stage 1 drilling program is being conducted with our partner there, Andrada Mining. And beyond having confirmed some very good grades at surface, we've also confirmed several bodies of pegmatite, spodumene at depth in this case. How well spread they are, how big they are, remains to be seen, though. So it's still early days, and a second stage of exploration is something we expect during this year as well. And last, on Canada, as you're well aware, SQM Canada was established by us for exploration purposes last year, and our own land in Canada is currently being explored as we speak.
In the press release, you brought up certain supply disruptions affecting the lithium market. I just want to confirm whether that ties to the reports we've been hearing out of Zimbabwe, or whether you've observed disruptions in other nations or regions? My second question concerns the permit process for Salar Futuro. Do you have any timing or schedule for when we might get news on that?
Juraj, regarding the disruptions in the lithium market, I think what you're getting at relates to when we discussed supply, and that was chiefly tied to certain lepidolite producers during the second half of last year who faced some government restrictions in China, which ultimately led to some of them halting their production.
Carlos back with you. Regarding Salar Futuro, our efforts there are ongoing, and our plan is to submit the environmental approval request around the midpoint of this year.
I really appreciate it. That brings us to the end of the conference call and Q&A session for today. Thanks to everyone for joining in. You're welcome to disconnect at this point.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Sociedad Química y Minera de Chile S.A. transcript - plus 132,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Sociedad Química y Minera de Chile S.A. earnings transcripts and 132,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $162 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.